Yoshiji Hantani

8PUBLICATIONS
7CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsMolecular medicineGlycoconjugatesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2024
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Kazuki Otake, Yoshinori Hara, Minoru Ubukata

|Jul 06, 2023
Fragment-Based Discovery of Novel VE-PTP Inhibitors Using Orthogonal Biophysical Techniques.

Wataru Asano, Kenji Yamanaka, Yasunori Ohara

|May 17, 2023
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1-Nrf2 PPI Inhibitor.

Kazuki Otake, Minoru Ubukata, Noboru Nagahashi

|Sep 08, 2021
SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction.

Seiji Kawashita, Koichi Aoyagi, Kyoko Fukushima

|Mar 13, 2020
Assay Development and Screening for the Identification of Ganglioside GM3 Synthase Inhibitors.

Kenji Yamanaka, Yu Takahashi, Yuya Azuma

|Jun 28, 2019
Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation.

Rie Hantani, Saya Hanawa, Shohei Oie

Pageof 2